RECOMBINANT HUMAN INSULIN REGULAR CARTRIDGES

Recombinant human insulin regular cartridges contain regular insulin, a fast-acting insulin produced using recombinant DNA technology. This insulin closely resembles human insulin and is used for managing blood sugar levels in people with diabetes. The cartridges are designed for use with insulin pens, allowing for convenient and precise dosing.

Indications

Recombinant human insulin regular cartridges are indicated for the treatment of diabetes mellitus, including both type 1 and type 2 diabetes. It helps regulate blood glucose levels by facilitating the uptake of glucose into cells and inhibiting the liver's production of glucose.

Dosage

Starting Dose: The dosage of recombinant human insulin regular cartridges varies depending on the individual's needs, medical history, and response to treatment. Dosage should be individualized and adjusted based on blood glucose monitoring.

Contra-Indications

-Known hypersensitivity to insulin or any component of the formulation. -Avoid use during episodes of hypoglycemia (low blood sugar).

Special Precautions

-Hypoglycemia: Monitor blood glucose levels regularly to avoid hypoglycemia, which can be life-threatening. -Insulin Resistance: Insulin resistance may occur; discuss any changes in insulin needs with a healthcare provider. -Injection Sites: Rotate injection sites to prevent lipodystrophy. -Storage: Store unused cartridges in a refrigerator and protect them from extreme temperatures.

Side Effects

-Common: Hypoglycemia, injection site reactions (pain, redness, swelling). -Less Common: Allergic reactions, weight gain, lipodystrophy. -Severe: Anaphylaxis or other severe allergic reactions; seek immediate medical attention.

Drug Interactions

-Hypoglycemic agents: May increase the risk of hypoglycemia. -Beta-blockers: May mask symptoms of hypoglycemia. -Corticosteroids and other drugs: May require adjustment of insulin dosage due to changes in blood glucose control.